My Passport
News and Commentary education Live Coronavirus Dashboard
S&P 500 ETF
0.00%
NASDAQ ETF
0.00%
Dow Jones ETF
0.00%


Nike Analyst Turns Bullish: 'Visible Recovery...
UPS Faces Post-SurePost Challenges: Analyst S...
December Jobs Report A 'Wake-Up Call For Anyo...
SpaceX, Apple, Airbnb And More Companies Pitc...
Delta Expands Premium Travel Experience with...
Match Group, Bumble's Growth Stalls: Analyst...
Consumer Inflation Worries Highest Since 2008...
Supreme Court Hears TikTok Arguments With App...
The Rise of the Solo General Partner Investor

While modern day venture capital originated in the 1940s, the very first iteration of venture capital (VC) investments--where a general partner (GP) investments capital on behalf of a limited partner (LP)--dates all the way back to the early 1600s with the founding of East India...

  • How are Higher Rates Impacting the Housi...
  • Quantitative Tightening: How the Fed Co...
  • Should Investors Worry About Inflation?
  • How Semiconductors are Made and Why its...
  • What Are NFTs?
    • Inflation: What is it and How to Protect From...
    Short Squeezes Could Lead to Market Dislocati...
    How Google and Facebook Antitrust Lawsuits Co...
    Vaccine News Triggers Growth to Value Rotatio...
    Energy
    Materials
    Industrial
    Finance
    Consumer D...
    Consumer S...
    Informatio...
    Telecommun...
    Health Car...
    Utilities
    Oil
    Gold
    ETFs IPOs Ratings
     
    S&P 500 ETF
    0.00%
    NASDAQ ETF
    0.00%
    Dow Jones ETF
    0.00%
    Search
    News and Commentary
    Education
    Market
    ETFs
    IPOs
    Ratings
    Newsfeed
    My passport
    Login
    Sign up

    MODERNA INC (NASDAQ: MRNA)

    Overview
    current price
    $42.25
    $42.25
    change
    -0.92 | -2.13%
    -0.92 | -2.13%
    Yesterday's Close
    43.17
    open
    42.77
    volume
    6.41 M
    30d. avg volume.
    8.40 M
    1 day
    41.79 - 43.70
    52 weeks
    35.80 - 170.47
    p/e
    0.00
    beta
    1.5971
    market cap
    16.26 B
    dividend yield
    0.00%
    Industry
    -
    MRNA by TradingView
    News and Commentary
    Bird Flu Sparks Vaccine Stock Surge: ETFs To Watch As H5N1 Outbreak Intensifies The U.S. reported its first human death from the H5 bird flu strain this week, causing a spike in vaccine developer stocks Moderna
    US Records First Human Bird Flu Death, High Levels Of Respiratory Illnesses: Vaccine Stocks Rally The Louisiana Department of Health on Monday reported the first human death in the U.S. related to the H5N1 bird flu virus. The CDC is also reporting high levels of acute respira...
    Bird Flu Found In Raw Milk Leads To Recall In California Bird flu has been detected in a batch of raw milk sold in California and a voluntary recall of the milk has been issued at the request of the state's department of public health....
    Moderna Remains Confident Despite Political Concerns Over Vaccine Safety and HHS Nomination Last week, some large European and U.S. vaccine maker stocks fell in reaction to Robert F. Kennedy Jr.'s nomination to lead the Department of Health and Human Services.
    Market Update: Stocks Slip Lower as Postelection Rally Falters Stocks declined on Friday as the postelection rally waned, leading all three major averages to post weekly losses. The Dow Jones Industrial Average sunk over 300 points, while th...
    Moderna's Q3 Earnings Beat Overshadowed By Vaccine Demand Slowdown And Market Share Concerns, Analys... On Thursday, Moderna Inc. (MR...
    Market Update: S&P 500, Nasdaq Reach New Record Following Fed Interest Rate Cuts The S&P 500 Index and Nasdaq Composite rose to another record high on Thursday as the broader market continued its rally following Donald Trump's election victory and reacted to...
    Goldman Sachs Highlights 20 Top Short-Squeeze Opportunities For Q3 Earnings Season Goldman Sachs identified 20 stocks with high short interest that could be primed for a short squeeze, particularly if upcoming earnings reports exceed expectations, providing opp...
    Moderna Hit With Another Lawsuit Related To Key COVID-19 Vaccine Technology Northwestern University has filed a patent infringement lawsuit against Moderna, Inc.
    The Covid Era Tech Promises To Reinvent Cancer Treatment Pfizer Inc (PFE 
    StockTwits
    StockTwits
    Most Shared
    Rivian's Strong Deliveries, R2 Line Plans And VW JV Expansion Drive Analyst Optimism
    Apple's iPhone 16 Stumbles On 'Intelligence' Awareness, But Pro Max Shines Bright: Analyst
    BoFA Expects Delta to Maintain 10% EPS Growth in 2025, Sees Strong Q4 Result
    Most Popular
    Tesla Analysts On Deliveries: EV Stock Could Have 'Stormy Weather' In Short Term, 'Generational Set Of Growth Opportunities' Long Term
    JetBlue Fined $2 Million For 'Chronic Flight Delays': Delta, United Rank Among Most On-Time Airlines
    Toyota 2024 US Sales Surge 3.7%, Hits Milestone With Over A Million Electrified Vehicles Sold
    popular tags
    Earnings
    Coronavirus
    Apple
    Amazon
    Coronavirus Impact
    Covid-19
    Google
    Tesla
    Covid19
    mobile iOS
    social Facebook Twitter Youtube Linkedin Rss Google News
    Passport to Wall Street About Us Contact Advertise Privacy Policy Terms of Service
    Sign Up
    © 2025 Passport to Wall Street
    Quotes are at least 20 minutes delayed

    Join now and unlock premium features

    Already Have An Account?